Free Trial

Curaleaf (OTCMKTS:CURLF) Trading Down 11.5% - Time to Sell?

Curaleaf logo with Medical background

Key Points

  • Curaleaf Holdings, Inc. shares fell by 11.5% to $1.70, with trading volume declining by 41% compared to its average session.
  • The company reported a quarterly EPS of ($0.07), aligning with analysts' expectations, while facing a negative net margin and return on equity.
  • Curaleaf operates in the cannabis industry, offering a range of products including flower, concentrates, and edibles.
  • Want stock alerts on Curaleaf? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report)'s share price traded down 11.5% during trading on Wednesday . The stock traded as low as $1.66 and last traded at $1.70. 382,399 shares changed hands during trading, a decline of 41% from the average session volume of 647,366 shares. The stock had previously closed at $1.92.

Wall Street Analyst Weigh In

Separately, Cormark upgraded Curaleaf from a "hold" rating to a "moderate buy" rating in a research report on Friday.

View Our Latest Research Report on Curaleaf

Curaleaf Price Performance

The stock has a fifty day moving average of $1.07 and a two-hundred day moving average of $1.05. The stock has a market capitalization of $1.37 billion, a price-to-earnings ratio of -6.38 and a beta of 0.69. The company has a current ratio of 1.41, a quick ratio of 0.70 and a debt-to-equity ratio of 1.08.

Curaleaf (OTCMKTS:CURLF - Get Free Report) last released its earnings results on Wednesday, August 6th. The company reported ($0.06) EPS for the quarter, beating the consensus estimate of ($0.07) by $0.01. Curaleaf had a negative return on equity of 14.41% and a negative net margin of 18.08%. As a group, equities research analysts forecast that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current year.

About Curaleaf

(Get Free Report)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

Featured Articles

Should You Invest $1,000 in Curaleaf Right Now?

Before you consider Curaleaf, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.

While Curaleaf currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

$15 Billion for Cybersecurity: The Government’s Next Big Push
Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines